Regencell Bioscience Holdings Ltd RGC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Regencell Deadline Today: Rosen Law Firm Urges Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
-
RGC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
-
Deadline Soon: Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
-
RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Securities Lawsuit - Contact Levi & Korsinsky
-
RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit
-
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
-
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers - RGC
Trading Information
- Previous Close Price
- $4.78
- Day Range
- $4.51–5.12
- 52-Week Range
- $4.51–69.00
- Bid/Ask
- $4.96 / $5.01
- Shares Outstanding
- 494.49M
- Market Cap
- $2.48B
- Volume/Avg
- 152,744 / 262,689
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people’s immune systems.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Value
- Total Number of Employees
- 10
Valuation
|
Metric
|
RGC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2,037.71 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
RGC
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
RGC
Profitability
|
Metric
|
RGC
|
|---|---|
Return on Assets (Normalized) | −130.14% |
Return on Equity (Normalized) | −165.27% |
Return on Invested Capital (Normalized) | −158.52% |
Return on Assets
RGC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|nD&H#D^^ | LOCK|<%zq | $68B | |||
| Haleon PLC ADR
HLN
| LOCK|Czz@#Gq | LOCK|N> | $44B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| LOCK|wtq^HTP | LOCK|R&m@# | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|#PqlP>j | LOCK|<Pb | $32B | |||
| Viatris Inc
VTRS
| LOCK|B<zXlL | LOCK|@R$ | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|#& | LOCK|## | $13B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|V<MhtcM | LOCK|nn! | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|Yr$##d | LOCK|#&P | $8B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|!FJyvCB | LOCK|S<@k | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|N<CQhL | LOCK|W!Z | $1B |
United States